SciClone Pharmaceuticals (SCLN +0.5%) updates its 2013 outlook, now expecting an initial EPS of...

|About: SciClone Pharmaceuticals, Inc. (SCLN)|By:, SA News Editor

SciClone Pharmaceuticals (SCLN +0.5%) updates its 2013 outlook, now expecting an initial EPS of $0.66 - $0.72 per share on revenues of between $150M - $155M. Analysts are looking for the company to earn $0.65 on revenue of around $152M.